A carregar...
Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?
BACKGROUND: Brazil became the first developing country to guarantee free and universal access to HIV/AIDS treatment, with antiretroviral drugs (ARVs) being delivered to nearly 190,000 patients. The analysis of ARV price evolution and market dynamics in Brazil can help anticipate issues soon to affli...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3156239/ https://ncbi.nlm.nih.gov/pubmed/21858138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0023478 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|